Phio CEO to Speak at Wainwright Conference in New York in September
06 sept. 2023 07h30 HE
|
Phio Pharmaceuticals Corp.
MARLBOROUGH, Mass., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Phio Pharmaceuticals (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to...